 2019;58:S1-109.e33.
21. 10. Cardiovascular Disease and Risk Management: Standards
of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):
S144-74.
22. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.
Diabetes Care 2022;45(Suppl. 1):S83-96.
23. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M,
Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Rev Esp Cardiol (Engl
Ed) 2018;71:111.
24. van Netten JJ, Bus SA, Apelqvist J, Chen P, Chuter V, Fitridge R, et al.
International Working Group on the Diabetic Foot. DeÔ¨Ånitions and
criteria for diabetes-related foot disease (IWGDF 2023 update).
Diabetes Metab Res Rev 2023. doi: 10.1002/dmrr.3654. [Epub ahead
of print.].
25. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K,
Duncan BB, et al. IDF Diabetes Atlas: Global, regional and countrylevel diabetes prevalence estimates for 2021 and projections for
2045. Diabetes Res Clin Pract 2022;183:109119.
26. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their
recurrence. New Engl J Med 2017;376:2367-75.
27. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR,
Smith DG. A prospective study of risk factors for diabetic foot ulcer.
The Seattle Diabetic Foot Study. Diabetes Care 19